Department. of Orthopaedics, Liaquat National Hospital, Karachi, Pakistan.
J Pak Med Assoc. 2023 Feb;73(Suppl 1)(2):S26-S31. doi: 10.47391/JPMA.AKUS-05.
To identify and evaluate the effectiveness of mesenchymal stem cells (MSCs) in augmenting healing in fracture non-unions.
A focused literature search was performed on the PubMed/MEDLINE index using the keywords: "non-union", "mesenchymal stem cells", "bone healing", "MSC", "stem cells", and their MeSH terms. The search was reiterated until the 10th of August 2022. Clinical studies were included that assessed the effect of MSCs on fracture non-unions.
Thirteen human clinical trials, studying a total of 318 participants were identified and studied. MSCs with and without biological or synthetic scaffolds were found to be effective in healing of non-unions.
MSCs has been demonstrated to have promising outcomes in the treatment of bone non-union and tissue engineering methods utilizing MSCs may well prove to be valuable in accelerating the process of bone union. However, clinical application of MSCs as a standard method in achieving union in fracture non-unions requires larger clinical trials with a standardised approach to analyzing outcomes.
确定和评估间充质干细胞(MSCs)在促进骨折不愈合愈合中的作用。
使用关键词“骨不连”、“间充质干细胞”、“骨愈合”、“MSC”、“干细胞”及其 MeSH 术语,在 PubMed/MEDLINE 索引上进行了针对性文献检索。该检索一直持续到 2022 年 8 月 10 日。纳入评估 MSCs 对骨折不愈合影响的临床研究。
共确定并研究了 13 项人类临床试验,总计 318 名参与者。发现含有和不含有生物或合成支架的 MSC 均能有效治疗骨不连。
MSC 已被证明在治疗骨不连方面有很好的效果,并且利用 MSC 的组织工程方法可能在加速骨愈合过程中非常有价值。然而,将 MSCs 作为实现骨折不愈合愈合的标准方法的临床应用需要更大规模的临床试验,并采用标准化方法来分析结果。